Appointments

Lexicon Genetics Names Leaders For Screening, Medicinal Chemistry Programs

Published in Genomics and Genetics Weekly, October 5th, 2001

Lexicon Genetics Inc. has announced the senior leadership for its High-Throughput Screening and Medicinal Chemistry programs.

"Lexicon has assembled the expertise to rapidly implement an integrated gene-to-lead drug discovery platform," said Arthur T. Sands, MD, PhD, president and chief executive officer of Lexicon. By combining our in vivo mammalian validated targets with Lexicon Pharmaceuticals' chemical approaches to discover small-molecule drugs, the company is well-positioned to capture significantly higher value from the drug targets it discovers, noted Dr. Sands.

To facilitate these initiatives, S. David Kimball, PhD, has joined Lexicon as...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly

Source: Genomics and Genetics Weekly (2001-10-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry